Listing 11 - 19 of 19 | << page >> |
Sort by
|
Choose an application
The 2012 passage of Initiative 502 in Washington state removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industry. This report uses data from multiple sources to estimate the total weight of marijuana consumed in the state in 2013 to provide decisionmakers with baseline information about the size of the state's market.
Drug legalization -- Washington (State). --- Marijuana -- Law and legislation -- Washington (State). --- Marijuana industry -- Washington (State). --- Social Welfare & Social Work --- Social Sciences --- Substance Abuse --- Drug legalization --- Marijuana industry --- Marijuana --- Law and legislation --- Ganja --- Marihuana --- Cannabis industry --- Decriminalization of illegal drugs --- Drug decriminalization --- Legalization of illegal drugs --- Cannabis --- Herb industry --- Decriminalization --- Narcotic laws --- Weed (Marijuana) --- Botanical drug industry
Choose an application
U.S. demand for illicit drugs creates markets for Mexican drug- trafficking organizations (DTOs) and helps foster violence in Mexico. This paper examines how marijuana legalization in California might influence DTO revenues and the violence in Mexico.
Drug legalization -- California. --- Drug traffic -- Mexico -- Finance. --- Drug traffic -- Mexico -- Prevention. --- Marijuana -- Law and legislation -- California. --- Violent crimes -- Mexico -- Prevention. --- Marijuana --- Drug legalization --- Drug traffic --- Violent crimes --- Law - U.S. --- Law, Politics & Government --- State Law - except N.Y. --- Law and legislation --- Prevention --- Finance --- Drug control --- Organized crime
Choose an application
This report provides detailed information about state-legal cannabis production and sales in Washington, as well as insights about the total amount of tetrahydrocannabinol (THC) obtained from legal and illegal sources by Washington residents. Using data from Washington's traceability system, the authors estimate that approximately 26 metric tons (MT) of THC were sold in licensed retail stores in Washington from July 1, 2016, through June 30, 2017. About 18 MT were from flower, 6 MT from extracts for inhalation, and the remaining 1–2 MT from other products. This 26 MT is more than double the amount of THC sold in licensed stores in the previous year. Calculating the total amount of THC obtained by residents via legal and illegal sources is difficult with existing data sources, but using additional data from the National Survey on Drug Use and Health and a survey of cannabis users in Washington, author calculations suggest that in the third year after implementing a regulatory system for cannabis, between 40 percent and 60 percent of THC obtained by state residents was likely purchased in Washington's state-licensed stores. Learning more about why some residents are still obtaining cannabis products through other channels, what share of legal sales are to nonresidents, and the efficiency of various cannabis products at delivering THC and other cannabinoids would be fruitful areas for future analysis.
Choose an application
The growth in energy production in the tristate Appalachia region (southwestern Pennsylvania, northern West Virginia, and eastern Ohio) has spurred a demand for hiring workers proficient in science, technology, engineering, and mathematics (STEM) fields. This has created a focus on the importance of having high-quality K–12 STEM education in the tristate region, as well as on policies and programs to enable the supply of labor in STEM occupations and career fields to keep pace with evolving demand. A challenge in the region is that the supply of workers with STEM skills has not kept pace with STEM workforce demand, which limits the region's capacity to benefit from national and global economic advances. Recognizing the workforce and education challenges facing the energy and advanced manufacturing industries in the region, the Appalachia Partnership Initiative (API) was launched in 2014 and is committed to investing
Drug abuse --- Opioid abuse --- Fentanyl. --- Opioids. --- Forecasting. --- Government policy --- United States.
Choose an application
User sanctions influence the legal risk for participants in illegal drug markets. A change in user sanctions may change retail drug prices, depending on how it changes the legal risk to users, how it changes the legal risk to dealers, and the slope of the supply curve. Using a novel dataset with rich transaction-level information, this paper evaluates the impact of recent changes in user sanctions for marijuana on marijuana prices. The results suggest that lower legal risks for users are associated with higher marijuana prices in the short-run, which ceteris paribus, implies higher profits for drug dealers. Additionally, the findings have important implications for thinking about the slope of the supply curve and interpreting previous research on the effect of drug laws on demand for marijuana.
Choose an application
The synthetic opioid surge in the United States is a public health emergency. Synthetic opioids, principally fentanyl, were reported in more than 31,000 fatal overdoses, or two-thirds of all opioid-involved deaths, in 2018. In less than six years, the number of fatal overdoses involving synthetic opioids in the United States has risen tenfold, surpassing drug overdoses for heroin or prescription opioids by a factor of two. Perhaps even more troubling is the possible diffusion of synthetic opioids into non-opioid markets. In this report, the authors examine mortality data at the state level across several drug classes to better understand the evolution and concentration of overdose fatalities in the United States. They also analyze drug seizures of fentanyl and fentanyl analogs across states and over time to determine the overlap between supply-side indicators and state-level mortality data. The authors report three main findings. First, overdose deaths involving synthetic opioids and certain supply-side indicators of synthetic opioids have increased over time but remain concentrated in certain states. Second, there have been sharp increases in the share of heroin or cocaine overdoses that involve synthetic opioids; furthermore, there appears to have been an absolute decline in fatal overdoses involving heroin without synthetic opioids in a few states. Third, a substantial share of cocaine overdoses also mention synthetic opioids, suggesting that people who use cocaine are increasingly exposed to these drugs. The authors conclude that drug policy needs to account for how rapidly these potent opioids are upending the old order.
Choose an application
Legalizing marijuana in California would lead to a major decline in the pretax price, but the price for consumers will depend heavily on taxes, the regulatory regime structure, and how taxes and regulations are enforced. The lower price and nonprice effects will increase consumption, but it is unclear by how much. There is much uncertainty about the effect on public budgets; even minor changes in assumptions lead to major differences in outcomes.
Drug legalization -- California. --- Drug legalization -- Economic aspects -- California. --- Marijuana -- Law and legislation -- California. --- Marijuana industry -- Social aspects -- California. --- Marijuana --- Drug legalization --- Marijuana industry --- Law and legislation --- Economic aspects --- Social aspects
Choose an application
This report presents the findings from a study funded by the Swiss Federal Office of Public Health to identify and analyse alternatives to profit-maximising commercial models of cannabis supply for non-medical use. This report provides a detailed overview of the regulatory frameworks which have introduced such models and considers the available evidence on the consequences of their implementation.
Choose an application
Opioids play an outsized role in America's drug problems, but they also play a critically important role in medicine. Thus, they deserve special attention. Illegally manufactured opioids (such as fentanyl) are involved in a majority of U.S. drug overdoses, but the problems are broader and deeper than drug fatalities. Depending on the drugs involved, there can be myriad physical and mental health consequences associated with having a substance use disorder. And it is not just those using drugs who suffer. Substance use and related behaviors can significantly affect individuals' families, friends, employers, and wider communities. Efforts to address problems related to opioids are insufficient and sometimes contradictory. In this 600-page report, researchers provide a nuanced assessment of America's opioid ecosystem, highlighting how leveraging system interactions can reduce addiction, overdose, suffering, and other harms. At the core of the opioid ecosystem are the individuals who use opioids and their families. Researchers also include chapters on ten major components of the opioid ecosystem: substance use disorder treatment, harm reduction, medical care, the criminal legal system, illegal supply and supply control, first responders, the child welfare system, income support and homeless services, employment, and education. The primary audience for this book is policymakers, but it should also be useful for foundations looking for opportunities to create change that have often been overlooked. This report can help researchers better consider the full consequences of policy changes and help members of the media identify the dynamics of interactions that deserve more attention.
Opioid abuse --- Drug abuse --- Medication abuse --- Opioids --- Prevention. --- Social aspects --- Government policy --- United States
Listing 11 - 19 of 19 | << page >> |
Sort by
|